On 30 April 2021, the draft of a regulation for completely new clinical trials of medicinal products for human use, which implements Regulation 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repeals Directive 2001/20/EC, was published for public consultation.
Juliusz Krzyżanowski is a senior associate in Baker McKenzie's Warsaw office and a member of the Life Sciences group. He has over seven years' experience advising Polish and foreign companies operating in the healthcare sector. Prior to joining the Firm, he was the advisor to the Polish Minister of Health. He also co-headed the life sciences practice in a large law firm and practiced in various international law firms. Juliusz often participates as a speaker in various conferences and is an author of a number of publications.